Genetic, Teratogenic, and Low Birth Weight: Key Points for Review

Chromosomal and genetic problems

  • Humans have 4646 chromosomes, created by two gametes each with 2323 chromosomes.
  • Approximately 92%92\% of people do not develop a serious inherited condition by early adulthood; about 8%8\% do.
  • Not exactly 4646: about half of zygotes have more or fewer than 4646 chromosomes due to nondisjunction; many fail to duplicate, divide, differentiate, and implant.
  • Trisomies:
    • Trisomy 13 (Ptau): about 1/100001/10000 births.
    • Trisomy 18 (Edwards): about 1/50001/5000 births.
    • Trisomy 21 (Down syndrome): about 1/7001/700 births; characteristics often present and cognitive development typically slower.
  • Sex chromosome abnormalities:
    • Turner syndrome (XO): one sex chromosome in females; notable features include short stature and other developmental differences.
    • Other anomalies (e.g., XXX, XYY, XXY/Klinefelter): specific patterns in cognition, fertility, and maturation.
    • Frequency examples: Turner 1/3001/300; Klinefelter 1/7001/700 in males; XYY 1/10001/1000; XXX 1/10001/1000 in females.
  • Single-gene disorders:
    • Dominant: many are mild; some are not evident until adulthood (e.g., certain forms of Alzheimer's disease, Huntington's chorea, Marfan syndrome).
    • Recessive: more numerous; carriers are typically asymptomatic.
    • X-linked: hemophilia, Duchenne muscular dystrophy, fragile X syndrome (CGG repeats >200).
    • Common autosomal recessives in populations: ~1 in 1010 North American adults carries an allele for cystic fibrosis, thalassemia, or sickle cell disease.
    • Sickle cell: carriers can have malaria protection; multiple alleles exist; prevalence varies by ancestry (e.g., ~8%8\% in Americans with African ancestry).
  • Population genetics & polygenic traits:
    • Most health-related traits arise from many genes; Neanderthal ancestry contributes to some protections and susceptibilities (e.g., skin traits, certain diseases).
    • Genes can have both beneficial and harmful effects; interactions with environment shape outcomes (e.g., anxiety may be protective in some contexts and harmful in others).
  • Gene–environment interactions & nurture:
    • Innate susceptibilities interact with prenatal and postnatal environments; nurture often modulates genetic risk.
  • Teratogens, timing, and vulnerability:
    • Teratogens can cause visible birth defects or brain/behavioral issues; timing (critical/sensitive periods) is crucial.
    • Fathers and other relatives influence risk via stress or support; pregnancy itself is a critical window.
    • Some teratogens damage the brain at any time; alcohol is a key example with dose-related effects.
    • Male fetuses have higher vulnerability to teratogens than female fetuses (hazard rate varies by teratogen).
    • Folic acid: maternal folate status affects neural tube defects; folic acid supplementation reduces risk significantly.
  • Folic acid study example:
    • Supplemented mothers: neural tube defect rate rac1250rac{1}{250}
    • Non-supplemented mothers: rac13300rac{13}{300}; supplementation markedly lowers risk, though some genetically at risk may still have defects.
  • Innate vulnerability and nurture interplay:
    • Genes set tendencies for moods, imagination, empathy; experiences shape how those tendencies express themselves.

Teratogens and prenatal development

  • Critical periods: damage can occur during specific gestational windows; some insults occur before pregnancy is known.
  • Timing matters for behavioral teratogens: second half of pregnancy can be especially sensitive to binge alcohol exposure.
  • Dose thresholds: many teratogens have a level above which damage occurs; no universally safe dose for psychoactive substances.
  • Alcohol as teratogen:
    • Fetal alcohol syndrome (FAS): facial distortions and growth issues when exposure is heavy early.
    • Fetal alcohol effects (FAD): behavioral and developmental effects later; no safe level established.
  • Genetic susceptibility to teratogens:
    • Male fetuses may be more vulnerable to some teratogens.
    • Maternal alleles affecting folic acid metabolism can increase neural tube defect risk in offspring; supplementation mitigates risk.
  • Prevention during pregnancy:
    • Avoid teratogens, ensure good nutrition, folic acid supplementation, up-to-date immunizations, appropriate weight gain.

Low birth weight (LBW) and outcomes

  • Definitions:
    • LBW: <2500\text{ g}
    • Very low birth weight (VLBW): <1500\text{ g}
    • Extremely low birth weight (ELBW): <1000\text{ g}
    • Normal birth weight: between 2500 g2500\text{ g} and about 4000 g4000\text{ g}.
  • Prevalence:
    • US LBW: 0.08=8%\approx 0.08 = 8\% of births.
    • Lowest rates: some high-income nations (e.g., Sweden) < 4%4\%; higher rates in others (varies by year and country).
  • Causes:
    • Maternal malnutrition, undernutrition, and poor diet; weight gain of less than about 1.3 kg1.3\text{ kg} per month in the last 6 months is linked to LBW.
    • Psychoactive drug use (including cigarettes and alcohol).
    • Multiple births (twins/triplets) and associated slower weight gain.
  • Consequences across development:
    • Every milestone (smiling, feeding, walking, talking) can be delayed in LBW infants.
    • Higher risk of cognitive, visual, and hearing impairments; later life risks include diabetes, obesity, heart disease, depression.
    • SGA (small for gestational age) includes full-term babies who are small; LBW can be due to prematurity or growth restriction.
  • Long-term plasticity:
    • Some LBW individuals catch up in brain development by age ~4 if no major health issues; adult outcomes vary.
  • Immigrant paradox:
    • Babies of immigrant mothers often heavier and healthier than native-born peers of similar SES; hypotheses include strong social support and healthier behaviors.
  • Trends and context (US):
    • LBW rates rose to around 0.0828=8.28%0.0828 = 8.28\% by 2018 after prior declines; multiple factors proposed (nutrition, stress, access to care, unintended pregnancies, obesity/diabetes in mothers).
    • Fewer multiple births due to assisted reproduction, yet LBW rates rise, suggesting other factors (nutrition, healthcare access) are at play.
  • Prevention and public health implications:
    • Improve nutrition, reduce drug use, enhance prenatal care, and support for expectant families.
    • Macro- and microsystem factors (socioeconomic status, immigration status) influence LBW risk; immigrant paradox suggests social support buffers risk.
    • Global patterns: LBW declines with better prenatal care in some countries (e.g., Cuba, Chile, China); rises in others due to hunger, disease, conflict.
  • Takeaway:
    • LBW is a key predictor of lifelong health; preventing LBW through nutrition, health care, and social support yields broad benefits.